Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Michael M. Cubrilo who wrote (784)	5/20/1998 12:15:00 PM
From: Edward W. Richmond	Read Replies (3) \| Respond to of 1185

Michael, good post. You have to be nimble to be a market timer. To both get out and then re-enter the market at the correct point in the stock price movement isn't for me, but good luck to you. I haven't received my copy of Investors Digest. When I do read the article, I will remember that Gordon Capital was one of the underwriters of the recent private placement in which I tried to participate. Fortunately, I was able to buy below the private placement price. Keep us posted of you decisions regarding Nortran. Regards, Ed

To: Michael M. Cubrilo who wrote (784)	5/20/1998 8:48:00 PM
From: Wisee	Read Replies (3) \| Respond to of 1185

Michael or anybody else, Can you please re-publish (in it's entirety) Golden Capital's recent buy recommendation on Nortran?? What is the target price?? Thank You, Wisee